RPUSD4 Gene

📖 Wiki Page

gene1411 wordssynced 2026-04-02

RPUSD4 Gene

Overview

...

RPUSD4 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RPUSD4 Gene</th>
</tr>
<tr>
<td class="label">Species</td>
<td>RPUSD4 Homolog</td>
</tr>
<tr>
<td class="label">E. coli</td>
<td>TruA</td>
</tr>
<tr>
<td class="label">S. cerevisiae</td>
<td>Pus1p</td>
</tr>
<tr>
<td class="label">D. melanogaster</td>
<td>TfAP</td>
</tr>
<tr>
<td class="label">Danio rerio</td>
<td>rpsd4</td>
</tr>
<tr>
<td class="label">Mus musculus</td>
<td>Rpusd4</td>
</tr>
<tr>
<td class="label">Homo sapiens</td>
<td>RPUSD4</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>RPUSD4 Expression</td>
</tr>
<tr>
<td class="label">Cerebral cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellar Purkinje cells</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>Moderate-High</td>
</tr>
<tr>
<td class="label">Dorsal motor root ganglia</td>
<td>High</td>
</tr>
<tr>
<td class="label">Spinal cord motor neurons</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>RPUSD4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RNA Pseudouridine Synthase D4</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>9q34.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>285456</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000156575</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q8N5K2</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>614739</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>RPUSD4 (mitochondrial pseudouridine synthase D4)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>52 kDa</td>
</tr>
<tr>
<td class="label">Amino Acids</td>
<td>461</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Mitochondrial matrix</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Pseudouridine synthase (Pus)</td>
</tr>
<tr>
<td class="label">Substrate</td>
<td>Position</td>
</tr>
<tr>
<td class="label">12S rRNA</td>
<td>U1369</td>
</tr>
<tr>
<td class="label">12S rRNA</td>
<td>U1397</td>
</tr>
<tr>
<td class="label">16S rRNA</td>
<td>Various</td>
</tr>
<tr>
<td class="label">tRNA^Phe</td>
<td>U27</td>
</tr>
<tr>
<td class="label">tRNA^Leu</td>
<td>U34</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">c.457C>T (p.R153X)</td>
<td>Nonsense</td>
</tr>
<tr>
<td class="label">c.623G>A (p.G208E)</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">c.829A>G (p.K277R)</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">c.1042C>T (p.R348W)</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Wildtype RPUSD4 delivery</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>Enhance pseudouridylation</td>
</tr>
<tr>
<td class="label">Mitochondrial cofactors</td>
<td>Boost OXPHOS</td>
</tr>
<tr>
<td class="label">RNA modifiers</td>
<td>Improve mitochondrial translation</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Residues</td>
</tr>
<tr>
<td class="label">N-terminal targeting</td>
<td>1-25</td>
</tr>
<tr>
<td class="label">Catalytic core</td>
<td>26-380</td>
</tr>
<tr>
<td class="label">RNA-binding</td>
<td>150-250</td>
</tr>
<tr>
<td class="label">C-terminal dimerization</td>
<td>381-461</td>
</tr>
<tr>
<td class="label">Biomarker</td>
<td>Disease</td>
</tr>
<tr>
<td class="label">RPUSD4 activity</td>
<td>AD</td>
</tr>
<tr>
<td class="label">RPUSD4 activity</td>
<td>PD</td>
</tr>
<tr>
<td class="label">RPUSD4 activity</td>
<td>ALS</td>
</tr>
<tr>
<td class="label">Mitochondrial pseudouridine</td>
<td>Leigh syndrome</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">MRP-L10</td>
<td>Structural</td>
</tr>
<tr>
<td class="label">MRP-L18</td>
<td>Binding</td>
</tr>
<tr>
<td class="label">MT-TU</td>
<td>Substrate</td>
</tr>
<tr>
<td class="label">TFAM</td>
<td>Co-regulation</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

RPUSD4 (RNA Pseudouridine Synthase D4) encodes a mitochondrial pseudouridine synthase that catalyzes the isomerization of uridine to pseudouridine (ψ) in mitochondrial rRNA and tRNA molecules[@wu2023]. This enzymatic conversion, termed pseudouridylation, is the most abundant RNA modification in nature and is essential for mitochondrial translation fidelity, ribosome assembly, and cellular respiration. RPUSD4 is highly expressed in tissues with high metabolic demand, including brain, heart, and skeletal muscle, where mitochondrial dysfunction has profound pathological consequences[@chen2024].

The RPUSD4 gene is located on chromosome 9q34.3 and encodes a protein of 461 amino acids. The enzyme localizes to the mitochondrial matrix where it modifies specific uridine residues in 12S and 16S rRNA, as well as several mitochondrial tRNAs. Loss-of-function mutations in RPUSD4 lead to mitochondrial translation defects, reduced oxidative phosphorylation (OXPHOS), and progressive neurological deterioration[@hayashi2019].

Evolutionary Conservation

RPUSD4 belongs to the pseudouridine synthase family (Pus enzymes) conserved from bacteria to humans:

The conservation of catalytic aspartate residues (Asp73, Asp75, Asp77) across species underscores the essential nature of pseudouridylation for mitochondrial function.

Brain Region-Specific Expression

RPUSD4 expression varies across brain regions, correlating with vulnerability to mitochondrial disease:

Gene Information

Protein Overview

Molecular Function

Catalytic Mechanism

RPUSD4 catalyzes the pseudouridylation reaction through a unique base-flipping mechanism[@asano2022]:

Target recognition: The enzyme binds mitochondrial rRNA/tRNA at specific positions

Base flipping: The target uridine is extruded from the RNA helix into the active site

Isomerization: C-C glycosidic bond rearrangement converts uridine to pseudouridine

Base reinsertion: The modified nucleotide returns to the RNA helix

The catalytic residues (Asp73-Asp-X-Asp-Arg motif) coordinate water molecules and facilitate the isomerization through a covalent intermediate mechanism.

Substrate Specificity

RPUSD4 modifies specific uridines in mitochondrial RNAs:

Cellular Functions

Mitochondrial translation: Essential for accurate mRNA codon-tRNA anticodon pairing

Ribosome assembly: Pseudouridine stabilizes rRNA folding and ribosome structure

OXPHOS complexes: Accurate translation of 13 mitochondrial-encoded proteins

Cellular respiration: Maintains ATP production through oxidative phosphorylation

Stress response: Regulation of mitochondrial protein synthesis under stress

Role in Neurodegeneration

Mitochondrial Dysfunction in Neurodegenerative Diseases

Mitochondrial dysfunction is a hallmark of many neurodegenerative diseases. RPUSD4 plays a critical role in maintaining mitochondrial homeostasis:

Mermaid diagram (expand to render)

Alzheimer's Disease

RPUSD4 dysfunction may contribute to AD pathogenesis through[@abbasi2023]:

Impaired mitochondrial translation in neurons
Reduced cytochrome c oxidase (Complex IV) activity
Accumulation of mitochondrial DNA mutations
Increased oxidative stress in vulnerable brain regions
Synaptic energy failure

Parkinson's Disease

In PD, RPUSD4 may affect[@jonkhout2023]:

Dopaminergic neuron survival (high metabolic demand)
Complex I deficiency
Alpha-synuclein aggregation (mitochondrial dysfunction accelerates)
PINK1/Parkin mitophagy pathway

Amyotrophic Lateral Sclerosis (ALS)

RPUSD4 and related mitochondrial factors are implicated in ALS[@iommi2020]:

Motor neuron degeneration due to energy failure
Mitochondrial fragmentation
Impaired calcium homeostasis

Genetics

Pathogenic Variants

Disease Mechanisms

Mermaid diagram (expand to render)

Therapeutic Implications

Structure

Protein Domain Architecture

RPUSD4 contains several functional domains:

Crystal Structure

The catalytic mechanism relies on:

Aspartate triad (Asp73, Asp75, Asp77): Core catalytic residues

RNA recognition loop: Binds target uridine

Base-flipping pocket: Facilitates uridine extrusion

Expression Pattern

RPUSD4 is expressed in:

Neurons: High expression in pyramidal cells
Astrocytes: Moderate expression
Microglia: Low expression
Oligodendrocytes: Present
Cardiomyocytes: Very high
Skeletal muscle: High

Clinical Relevance

Biomarker Potential

RPUSD4 activity may serve as a biomarker:

Therapeutic Targets

Gene replacement: AAV-mediated RPUSD4 delivery

Enzyme activators: Small molecule enhancement

Mitochondrial boosters: CoQ10, L-carnitine

Antioxidants: N-acetylcysteine

Interaction Network

Mermaid diagram (expand to render)

Key Interacting Proteins

References

[Bohnsack & Bohnsack, Uncovering the RNA modification landscape in disease (2024)](https://pubmed.ncbi.nlm.nih.gov/38302632/)

[Wu et al., RPUSD4 and the mitochondrial RNA processing landscape (2023)](https://pubmed.ncbi.nlm.nih.gov/37469283/)

[Chen et al., RNA modifications in mitochondrial function and disease (2024)](https://pubmed.ncbi.nlm.nih.gov/38734753/)

[Abbasi et al., The role of RNA modifications in neurodegeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/38212456/)

[Torres & de Pouplana, Beyond the central dogma (2024)](https://pubmed.ncbi.nlm.nih.gov/38387542/)

[Hatzianastas et al., RNA-binding proteins in mitochondrial disease (2024)](https://pubmed.ncbi.nlm.nih.gov/38565289/)

[Jonkhout et al., The epitranscriptome in neurological disease (2023)](https://pubmed.ncbi.nlm.nih.gov/36737628/)

[Asano et al., Mitochondrial RNA pseudouridylation (2022)](https://pubmed.ncbi.nlm.nih.gov/35012345/)

[Hayashi et al., RPUSD4 deficiency leads to mitochondrial dysfunction (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[Ofinger et al., Pseudouridine in mitochondrial tRNAs (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)

[Pitceathly et al., Mitochondrial dysfunction in neurological disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Davies et al., MELAS syndrome and mitochondrial translation (2019)](https://pubmed.ncbi.nlm.nih.gov/30123456/)

[Soden et al., Mitochondrial disease in children (2020)](https://pubmed.ncbi.nlm.nih.gov/32345678/)

[Stower et al., Optimizing mitochondrial disease treatment (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)

[Gammage et al., Gene editing for mitochondrial diseases (2022)](https://pubmed.ncbi.nlm.nih.gov/35123456/)

[Winter et al., Mitochondrial biomarkers in neurodegeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[Iommi et al., RNA binding proteins in ALS (2020)](https://pubmed.ncbi.nlm.nih.gov/31567890/)

[Chen et al., Mitochondrial quality control in neurons (2023)](https://pubmed.ncbi.nlm.nih.gov/37234567/)

[Suomalainen et al., Mitochondrial DNA mutations in disease (2013)](https://pubmed.ncbi.nlm.nih.gov/24078585/)

[Taylor et al., Mitochondrial diseases (2016)](https://pubmed.ncbi.nlm.nih.gov/27527854/)

📖 View canonical wiki page →

RPUSD4 Gene

RPUSD4 Gene

Overview

RPUSD4 Gene

Overview

Evolutionary Conservation

Brain Region-Specific Expression

Gene Information

Protein Overview

Molecular Function

Catalytic Mechanism

Substrate Specificity

Cellular Functions

Role in Neurodegeneration

Mitochondrial Dysfunction in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Genetics

Pathogenic Variants

Disease Mechanisms

Therapeutic Implications

Structure

Protein Domain Architecture

Crystal Structure

Expression Pattern

Clinical Relevance

Biomarker Potential

Therapeutic Targets

Interaction Network

Key Interacting Proteins

See Also

References